Economy7 August 20264 min read
Medical devices conference opens in Delhi; white paper calls for servicing framework
The 9th India Medical Device 2026 conference began at Vigyan Bhawan, New Delhi. The Department of Pharmaceuticals Secretary said India must move beyond import substitution to build an export-oriented industry. The two-day event is organised by the Department of Pharmaceuticals, under the Ministry of Chemicals & Fertilizers, with the Federation of Indian Chambers of Commerce and Industry (FICCI). Its theme is 'Towards Viksit Bharat: Advancing India as a Global Hub for Quality Medical Devices'.
A FICCI-DUA Consulting White Paper on the service and maintenance of medical equipment was released on the opening day. It argues that manufacturing incentives alone will not sustain the sector's growth.
What officials said
Department of Pharmaceuticals Secretary Manoj Joshi said the sector has to be seen from both healthcare and industry perspectives. Healthcare providers want access to quality devices irrespective of their origin, he said, while domestic manufacturing matters for employment, industry capability and supply chain resilience, especially during global disruptions.
Joshi said India has made significant progress in local manufacturing, particularly in consumables, disposables and the assembly of high-end equipment, including diagnostics and imaging systems. He put the Indian market at around $16 billion, against a global market that exceeds $600 billion. To tap that potential, he called for stronger component manufacturing, deeper value addition, easier cross-border movement of components and products, integration into global value chains, and stronger partnerships between startups and large industries so that innovations reach the market. He also asked for innovation in advanced medical technologies and continuous improvement in quality standards.
Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi said the sector is moving from an import-driven market to one led by domestic manufacturing. He said India needs indigenous capability in high-end Class C and Class D medical devices and in vitro diagnostics, with faster, transparent and predictable regulatory approvals.
Tushar Sharma, Chair of the FICCI Medical Devices Committee, said industry has invested in R&D centres, Global Capability Centres, software and engineering hubs, clinical research, manufacturing, service networks and workforce development. FICCI Director General Jyoti Vij said the next phase of growth will depend on India's ability to foster innovation, build resilient supply chains, develop advanced manufacturing, promote globally harmonised quality standards, use digital technologies and expand its international footprint.
What the white paper says
The White Paper, titled 'Service and Maintenance of Medical Equipment in Indian Healthcare – Towards a Safe, Reliable and Sustainable Medical Device Maintenance Ecosystem', credits the Production Linked Incentive (PLI) Scheme and the Strengthening of Medical Devices Industry Scheme with improving domestic manufacturing capability and global competitiveness. Sustained growth, it says, will depend on manufacturing and also on a world-class ecosystem for servicing, maintenance, calibration and lifecycle management.
It values the sector at around $14 billion, projected to reach $30-50 billion within this decade and likely $250 billion by 2047. It cites rising healthcare demand, wider adoption of advanced medical technologies, government support for indigenous manufacturing and the ambition to become a global MedTech hub as drivers.
The paper says medical equipment supports timely diagnosis, emergency response, surgeries and advanced treatment, and that its value extends beyond procurement to reliable servicing across its operational life. Proper maintenance, it says, improves patient safety, enhances clinical effectiveness, reduces downtime, extends equipment life and makes better use of healthcare investment.
Recommendations
The White Paper proposes a risk-tiered hybrid maintenance framework anchored in the device classification system of the Central Drugs Standard Control Organisation (CDSCO). It recommends:
- maintenance protocols based on device risk categories;
- a national certification system for service engineers;
- stronger technical training;
- commercial model innovation;
- a rationalised fiscal framework to promote compliant maintenance practices;
- wider use of predictive maintenance, digital monitoring and lifecycle management systems to improve reliability and minimise downtime.
The paper presents these as a roadmap for a safe, transparent and sustainable medical equipment maintenance ecosystem.